Taking the right fork in the road: What are the criteria to choose between out-licensing vs. creating a company?

Edition

Taking the right fork in the road: What are the criteria to choose between out-licensing vs. creating a company?

How to valuate and make your project out? What are the best options among licensing, corporating or creating a start-up? On which grounds are TTOs advising to create a spin-off rather than out-licensing the IP or a contract-based R&D collaboration? What each of these alternatives entail? What kind of surroundings would you need for each of these options?

Jérôme Van Biervliet

Managing Director
Belgium
VIB

Lisa Urquhart

Editor
United Kingdom
Evaluate Vantage

Bobby Soni

Chief Business Officer
Denmark
BioInnovation Institute

Jason Mellad

CEO and Co-Founder
United Kingdom
Start Codon

Laetitia Szaller

General Counsel & VP Business Development
United Kingdom
AM Pharma

Tony Hickson

Chief Business Officer
United Kingdom
Cancer Research UK
  • No products in the cart.